LACTOSE (INDIA)
Back to Income Statement
|
LACTOSE (INDIA) Last 5 Year Consolidated Net Profit History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹1.21 Cr | ₹2.45 Cr | ₹-2.48 Cr | ₹0.07 Cr | ₹0.72 Cr |
What is the latest Consolidated Net Profit of LACTOSE (INDIA) ?
Year | Consolidated Net Profit |
---|---|
Mar2023 | ₹1.21 Cr |
Mar2022 | ₹2.45 Cr |
Mar2021 | ₹-2.48 Cr |
Mar2020 | ₹0.07 Cr |
Mar2019 | ₹0.72 Cr |
How is Consolidated Net Profit of LACTOSE (INDIA) Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2023 | ₹1.21 Cr | -50.67 | |
Mar2022 | ₹2.45 Cr | Positive | |
Mar2021 | ₹-2.48 Cr | Negative | |
Mar2020 | ₹0.07 Cr | -90.00 | |
Mar2019 | ₹0.72 Cr | - |
Compare Consolidated Net Profit of peers of LACTOSE (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LACTOSE (INDIA) | ₹213.8 Cr | -1.8% | 12.4% | 183.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹443,649.0 Cr | -0.6% | -3.7% | 66.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,465.0 Cr | 2% | 8.7% | 73% | Stock Analytics | |
CIPLA | ₹125,436.0 Cr | 4.3% | -6.6% | 18.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,321.0 Cr | -2.2% | -5.6% | 17% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,810.0 Cr | 1.2% | -7.3% | 70% | Stock Analytics |
LACTOSE (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LACTOSE (INDIA) | -1.8% |
12.4% |
183.2% |
SENSEX | -0.8% |
-5.8% |
24.5% |
You may also like the below Video Courses